Search Results for: Humira
Trending Drug PricingDrug ManufacturingMedication
New Trends of Hospital Pharmacy Expenditure: Specialty and Neurology Medications are Escalating
2023-08-09
Special Lawsuit
Genentech Takes Biogen to Court Over Stockpiled Multiple Sclerosis Drug Royalties
2023-03-01
Special Lawsuit
Dutch Pharmaceutical Watchdog Organization Sues Abbvie over Humira Pricing
2023-02-22
Trials & Approvals Biosimilar
Amgen’s Humira Biosimilar Now Available in the U.S.
2023-02-01
Special biopharmam&a
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Trials & Approvals Crohn’s disease
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
Licensing Autoimmune Disease
AbbVie & Cugene Join Forces to Tackle Autoimmune Diseases
2022-05-17
Technology HUMIRA
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
Asia-Pacific Biosimilar
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
Biosimilar
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
Cancer
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
Multiomics
ROSALIND Partners with Two Korean Biotechs to Expand Cancer Research in Asia
2021-04-16
Anti-TNF
Korea Made Humira Biosimilar Begins Sales in Australia, Marks its Presence in Third Overseas Market
2021-03-31
Tumor Organoids Partner
How Can Organoid and Mouse Models Boost Oncology Preclinical Trials? – Highlights from the Crown Biosciences Symposium
2021-03-10
Trials & Approvals Tapinarof
Dermavant Sciences’ Psoriasis Drug Promises in Phase 3 Trials
2021-02-20
1 2
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top